SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D F Gilmour, Familial exudative vitreoretinopathy and related retinopathies, Eye, 2015, 29, 1, 1

    CrossRef

  2. 2
    Gai-Li Li, Xian-Hua Xu, Bing-Ang Wang, Yi-Min Yao, Yang Qin, Shu-Rong Bai, Jian Rong, Tao Deng, Yong-He Hu, Analysis of protein-protein interaction network and functional modules on primary osteoporosis, European Journal of Medical Research, 2014, 19, 1, 15

    CrossRef

  3. 3
    Guang-Yue Xu, Yong Qiu, Hai-Jun Mao, Common Polymorphism in theLRP5Gene May Increase the Risk of Bone Fracture and Osteoporosis, BioMed Research International, 2014, 2014, 1

    CrossRef

  4. 4
    F.S. Van Dijk, D.O. Sillence, Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment, American Journal of Medical Genetics Part A, 2014, 164, 6
  5. 5
    Fiona J Cook, Steven Mumm, Michael P Whyte, Deborah Wenkert, Pregnancy-Associated Osteoporosis With a Heterozygous Deactivating LDL Receptor-Related Protein 5 (LRP5) Mutation and a Homozygous Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism, Journal of Bone and Mineral Research, 2014, 29, 4
  6. 6
    Frank Rauch, Liljana Lalic, Francis H. Glorieux, Pierre Moffatt, Peter Roughley, Targeted Sequencing of a Pediatric Metabolic Bone Gene Panel Using a Desktop Semiconductor Next-Generation Sequencer, Calcified Tissue International, 2014, 95, 4, 323

    CrossRef

  7. 7
    Stefano Stagi, Loredana Cavalli, Salvatore Seminara, Maurizio de Martino, Maria Brandi, The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment, Italian Journal of Pediatrics, 2014, 40, 1, 55

    CrossRef

  8. 8
    Yu Cai, Tiange Cai, Yan Chen, Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic, Journal of Cellular Biochemistry, 2014, 115, 4
  9. 9
    Jung-Min Kim, Jin Seok Choi, Yun-Hee Kim, Seong Hui Jin, Seyoung Lim, Hyun-Jun Jang, Kyong-Tai Kim, Sung Ho Ryu, Pann-Ghill Suh, An activator of the cAMP/PKA/CREB pathway promotes osteogenesis from human mesenchymal stem cells, Journal of Cellular Physiology, 2013, 228, 3
  10. 10
    P. P. Dwivedi, N. Lam, B. C. Powell, Boning up on glypicans—opportunities for new insights into bone biology, Cell Biochemistry and Function, 2013, 31, 2
  11. 11
    Justine Bacchetta, Katherine Wesseling-Perry, Vicente Gilsanz, Barbara Gales, Renata C Pereira, Isidro B Salusky, Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography, Pediatric Rheumatology, 2013, 11, 1, 6

    CrossRef

  12. 12
    Fleur S. van Dijk, M. Carola Zillikens, Dimitra Micha, Markus Riessland, Carlo L.M. Marcelis, Christine E. de Die-Smulders, Janine Milbradt, Anton A. Franken, Arjan J. Harsevoort, Klaske D. Lichtenbelt, Hans E. Pruijs, M. Estela Rubio-Gozalbo, Rolf Zwertbroek, Youssef Moutaouakil, Jaqueline Egthuijsen, Matthias Hammerschmidt, Renate Bijman, Cor M. Semeins, Astrid D. Bakker, Vincent Everts, Jenneke Klein-Nulend, Natalia Campos-Obando, Albert Hofman, Gerard J. te Meerman, Annemieke J.M.H. Verkerk, André G. Uitterlinden, Alessandra Maugeri, Erik A. Sistermans, Quinten Waisfisz, Hanne Meijers-Heijboer, Brunhilde Wirth, Marleen E.H. Simon, Gerard Pals, PLS3Mutations in X-Linked Osteoporosis with Fractures, New England Journal of Medicine, 2013, 369, 16, 1529

    CrossRef

  13. 13
    Evan Stiegel, Emil A.T. Say, B. Christian Carter, Matthew J. Thomas, Carol L. Shields, SIMULTANEOUS FZD4 AND LRP5 MUTATION IN AUTOSOMAL DOMINANT FAMILIAL EXUDATIVE VITREORETINOPATHY, Retinal Cases & Brief Reports, 2013, 7, 1, 26

    CrossRef

  14. 14
    Somayyeh Fahiminiya, Jacek Majewski, Peter Roughley, Paul Roschger, Klaus Klaushofer, Frank Rauch, Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density, Bone, 2013, 57, 1, 41

    CrossRef

  15. 15
    Craig Munns, David Sillence, Emery and Rimoin's Principles and Practice of Medical Genetics, 2013,

    CrossRef

  16. 16
    Leanne Ward, M. Zulf Mughal, Laura K. Bachrach, Osteoporosis, 2013,

    CrossRef

  17. 17
    Elise F. Morgan, George L. Barnes, Thomas A. Einhorn, Osteoporosis, 2013,

    CrossRef

  18. 18
    Mervi K Mäyränpää, Heli T Viljakainen, Sanna Toiviainen-Salo, Pentti E Kallio, Outi Mäkitie, Impaired bone health and asymptomatic vertebral compressions in fracture-prone children: A case-control study, Journal of Bone and Mineral Research, 2012, 27, 6
  19. 19
    Johanna Korvala, Harald Jüppner, Outi Mäkitie, Etienne Sochett, Dirk Schnabel, Stefano Mora, Cynthia F Bartels, Matthew L Warman, Donald Deraska, William G Cole, Heini Hartikka, Leena Ala-Kokko, Minna Männikkö, Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity, BMC Medical Genetics, 2012, 13, 1, 26

    CrossRef

  20. 20
    Nina S. Ma, Catherine M. Gordon, Pediatric Osteoporosis: Where Are We Now?, The Journal of Pediatrics, 2012, 161, 6, 983

    CrossRef

  21. 21
    Christine M. Laine, Dror Koltin, Miki Susic, Talia L. Varley, Alan Daneman, Rahim Moineddin, William G. Cole, Outi Mäkitie, Etienne Sochett, Primary osteoporosis without features of OI in children and adolescents: Clinical and genetic characteristics, American Journal of Medical Genetics Part A, 2012, 158A, 6
  22. 22
    Johanna Korvala, Marika Löija, Outi Mäkitie, Etienne Sochett, Harald Jüppner, Dirk Schnabel, Stefano Mora, William G. Cole, Leena Ala-Kokko, Minna Männikkö, Rare variations in WNT3A and DKK1 may predispose carriers to primary osteoporosis, European Journal of Medical Genetics, 2012, 55, 10, 515

    CrossRef

  23. 23
    Mervi K Mäyränpää, Inari S Tamminen, Heikki Kröger, Outi Mäkitie, Bone biopsy findings and correlation with clinical, radiological, and biochemical parameters in children with fractures, Journal of Bone and Mineral Research, 2011, 26, 8
  24. 24
    Nilay Sethi, Yibin Kang, Dysregulation of developmental pathways in bone metastasis, Bone, 2011, 48, 1, 16

    CrossRef

  25. 25
    C M Laine, B D Chung, M Susic, T Prescott, O Semler, T Fiskerstrand, P D'Eufemia, M Castori, M Pekkinen, E Sochett, W G Cole, C Netzer, O Mäkitie, Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG), European Journal of Human Genetics, 2011, 19, 8, 875

    CrossRef

  26. 26
    Joseph A. Lorenzo, Ernesto Canalis, Lawrence G. Raisz, Williams Textbook of Endocrinology, 2011,

    CrossRef

  27. 27
    In Gwun Jang, Il Yong Kim, Computational simulation of simultaneous cortical and trabecular bone change in human proximal femur during bone remodeling, Journal of Biomechanics, 2010, 43, 2, 294

    CrossRef

  28. 28
    Anne Saarinen, Tero Saukkonen, Tero Kivelä, Ulla Lahtinen, Christine Laine, Mirja Somer, Sanna Toiviainen-Salo, William G. Cole, Anna-Elina Lehesjoki, Outi Mäkitie, Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia, Clinical Endocrinology, 2010, 72, 4
  29. 29
    Anne Saarinen, Mervi K. Mäyränpää, Anna-Elina Lehesjoki, Outi Mäkitie, Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children, Bone, 2010, 46, 4, 940

    CrossRef

  30. 30
    Fulvio Lauretani, Chiara Cepollaro, Stefania Bandinelli, Antonio Cherubini, Alessia Gozzini, Laura Masi, Alberto Falchetti, Francesca Del Monte, Silvia Carbonell-Sala, Francesca Marini, Annalisa Tanini, Anna Maria Corsi, Gina Paolo Ceda, Maria Luisa Brandi, Luigi Ferrucci, LRP5 gene polymorphism and cortical bone, Aging Clinical and Experimental Research, 2010, 22, 4, 281

    CrossRef

  31. 31
    Konstantinos Nikopoulos, Hanka Venselaar, Rob W.J. Collin, Rosa Riveiro-Alvarez, F. Nienke Boonstra, Johanna M.M. Hooymans, Arijit Mukhopadhyay, Deborah Shears, Marleen van Bers, Ilse J. de Wijs, Anthonie J. van Essen, Rolf H. Sijmons, Mauk A.D. Tilanus, C. Erik van Nouhuys, Carmen Ayuso, Lies H. Hoefsloot, Frans P.M. Cremers, Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP, Human Mutation, 2010, 31, 6
  32. 32
    D. Cakouros, R. M. Raices, S. Gronthos, C.A. Glackin, Twist-ing cell fate: Mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis, Journal of Cellular Biochemistry, 2010, 110, 6
  33. 33
    Dimitrios Daoussis, Andrew P. Andonopoulos, Stamatis-Nick C. Liossis, Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis, Seminars in Arthritis and Rheumatism, 2010, 39, 5, 369

    CrossRef

  34. 34
    Luigi Gennari, Robert Klein, Serge Ferrari, Osteoporosis in Men, 2010,

    CrossRef

  35. 35
    Boi-Dinh Chung, Hülya Kayserili, Minrong Ai, Jan Freudenberg, Abdullah Üzümcü, Oya Uyguner, Cynthia F. Bartels, Stefan Höning, Alfredo Ramirez, Franz-Georg Hanisch, Gudrun Nürnberg, Peter Nürnberg, Matthew L. Warman, Bernd Wollnik, Christian Kubisch, Christian Netzer, A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats, Human Mutation, 2009, 30, 4
  36. 36
    Hui Li, Hui Xie, Wei Liu, Rong Hu, Bi Huang, Yan-Fei Tan, Er-Yuan Liao, Kang Xu, Zhi-Feng Sheng, Hou-De Zhou, Xian-Ping Wu, Xiang-Hang Luo, A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans, Journal of Clinical Investigation, 2009, 119, 12, 3666

    CrossRef

  37. 37
    Fabián A. Ramírez, Oswaldo Lazala, Federico Rondón, José Félix Restrepo, Antonio Iglesias Gamarra, Evidencia radiográfica de la acción de los bifosfonatos en el esqueleto inmaduro, Revista Colombiana de Reumatología, 2009, 16, 2, 146

    CrossRef

  38. You have free access to this content38
    Yan Chen, Benjamin A. Alman, Wnt pathway, an essential role in bone regeneration, Journal of Cellular Biochemistry, 2009, 106, 3
  39. 39
    Nick Bishop, Pierre Braillon, Jon Burnham, Rolando Cimaz, Justin Davies, Mary Fewtrell, Wolfgang Hogler, Kathy Kennedy, Outi Mäkitie, Zulf Mughal, Nick Shaw, Maria Vogiatzi, Kate Ward, Maria Luisa Bianchi, Dual-Energy X-ray Aborptiometry Assessment in Children and Adolescents with Diseases that May Affect the Skeleton: The 2007 ISCD Pediatric Official Positions, Journal of Clinical Densitometry, 2008, 11, 1, 29

    CrossRef

  40. 40
    N. J Shaw, Management of osteoporosis in children, European Journal of Endocrinology, 2008, 159, suppl_1, S33

    CrossRef

  41. 41
    Elizabeth A. Streeten, Daniel McBride, Eric Puffenberger, Marc E. Hoffman, Toni I. Pollin, Patrick Donnelly, Paul Sack, Holmes Morton, Osteoporosis-pseudoglioma syndrome: Description of 9 new cases and beneficial response to bisphosphonates, Bone, 2008, 43, 3, 584

    CrossRef

  42. 42
    F. Timo Beil, Sebastian Seitz, Mathias Priemel, Florian Barvencik, Christoph von Domarus, Johannes M. Rueger, Michael Amling, Pia Pogoda, Pathophysiology and Pathomorphology of Osteoporosis, European Journal of Trauma and Emergency Surgery, 2008, 34, 6, 527

    CrossRef

  43. 43
    Carmen E. Macsai, Bruce K. Foster, Cory J. Xian, Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair, Journal of Cellular Physiology, 2008, 215, 3
  44. 44
    Harry C. Blair, Mone Zaidi, Christopher L.-H. Huang, Li Sun, The Developmental Basis of Skeletal Cell Differentiation and the Molecular Basis of Major Skeletal Defects, Biological Reviews, 2008, 83, 4
  45. 45
    E.R. Barros, M.R. Dias da Silva, I.S. Kunii, M. Lazaretti-Castro, Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation, Journal of Pediatric Endocrinology and Metabolism, 2008, 21, 8

    CrossRef

  46. 46
    Régis Levasseur, Treatment and management of osteoporosis–pseudoglioma syndrome, Expert Review of Endocrinology & Metabolism, 2008, 3, 3, 337

    CrossRef

  47. 47
    Elke Piters, Eveline Boudin, Wim Van Hul, Wnt signaling: A win for bone, Archives of Biochemistry and Biophysics, 2008, 473, 2, 112

    CrossRef

  48. 48
    Mark L. Johnson, Principles of Bone Biology, 2008,

    CrossRef

  49. 49
    Lawrence G. Raisz, John P. Bilezikian, T. John Martin, Principles of Bone Biology, 2008,

    CrossRef

  50. 50
    Deborah Wenkert, Steven Mumm, Stefanie M Wiegand, William H McAlister, Michael P Whyte, Absence of MMP2 Mutation in Idiopathic Multicentric Osteolysis with Nephropathy, Clinical Orthopaedics and Related Research, 2007, 462, 80

    CrossRef

  51. 51
    Mark L. Johnson, Nalini Rajamannan, Diseases of Wnt signaling, Reviews in Endocrine and Metabolic Disorders, 2007, 7, 1-2, 41

    CrossRef

  52. 52
    Lawrence G. Raisz, Maintaining the life-long vitality and integrity of skeletal tissue, Bone, 2007, 40, 5, S1

    CrossRef

  53. 53
    Mone Zaidi, Skeletal remodeling in health and disease, Nature Medicine, 2007, 13, 7, 791

    CrossRef

  54. 54
    Anne Saarinen, Ville-Valtteri Välimäki, Matti J. Välimäki, Eliisa Löyttyniemi, Kirsi Auro, Piia Uusen, Mairi Kuris, Anna-Elina Lehesjoki, Outi Mäkitie, The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men, Bone, 2007, 40, 4, 1006

    CrossRef

  55. 55
    Lawrence G. Raisz, The osteoporosis revolution marches on, Journal of Orthopaedic Science, 2007, 12, 4, 405

    CrossRef

  56. 56
    Roland Baron, Georges Rawadi, Wnt signaling and the regulation of bone mass, Current Osteoporosis Reports, 2007, 5, 2, 73

    CrossRef

  57. 57
    Christina N Bennett, Hongjiao Ouyang, Yanfei L Ma, Qingqiang Zeng, Isabelle Gerin, Kyle M Sousa, Timothy F Lane, Venkatesh Krishnan, Kurt D Hankenson, Ormond A MacDougald, Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation, Journal of Bone and Mineral Research, 2007, 22, 12
  58. 58
    W.M.W. Cheung, L.Y. Jin, D.K. Smith, P.T. Cheung, E.Y.W. Kwan, L. Low, A.W.C. Kung, A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene, Bone, 2006, 39, 3, 470

    CrossRef

  59. 59
    Elzbieta Skowro??ska-J????wiak, Roman S Lorenc, Metabolic Bone Disease in Children, Treatments in Endocrinology, 2006, 5, 5, 297

    CrossRef

  60. 60
    M. Priemel, C. Münch, F. T. Beil, H. Ritzel, M. Amling, Pathophysiologie und Pathomorphologie der Osteoporose, Der Radiologe, 2006, 46, 10, 831

    CrossRef

  61. 61
    Serge Ferrari, Single gene mutations and variations affecting bone turnover and strength: a selective 2006 update, BoneKEy-Osteovision, 2006, 3, 12, 11

    CrossRef

  62. 62
    Minrong Ai, Shauna Heeger, Cynthia F. Bartels, Deborah K. Schelling, Clinical and Molecular Findings in Osteoporosis-Pseudoglioma Syndrome, The American Journal of Human Genetics, 2005, 77, 5, 741

    CrossRef

  63. 63
    Georges Rawadi, Sergio Roman-Roman, Wnt signalling pathway: a new target for the treatment of osteoporosis, Expert Opinion on Therapeutic Targets, 2005, 9, 5, 1063

    CrossRef

  64. 64
    Nick Bishop, Francis H. Glorieux, Juvenile Osteoporosis,